$SOLV News

Solventum Corporation (SOLV) Fell as Its HCIT Unit Hurt by AI Disruption Fears

Solventum to Participate in the 2026 Jefferies Healthcare Conference

What Are Wall Street Analysts' Target Price for Solventum Stock?

Wedbush Initiates Coverage of Solventum (SOLV) with Outperform Recommendation

SOLV or HQY: Which Is the Better Value Stock Right Now?

Solventum Seen Positioned for Meaningful Re-Rating Over Next 12 to 18 Months, Wedbush Says

Wedbush Initiates Coverage On Solventum with Outperform Rating, Announces Price Target of $94

Solventum’s Q1 Earnings Call: Our Top 5 Analyst Questions

Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average

Why Solventum (SOLV) Is Up 8.8% After Beating Adjusted Q1 Estimates And Reaffirming 2026 Outlook

Is It Time To Reassess Solventum (SOLV) After Its Recent Share Price Rebound?

Solventum to Participate in the 2026 BofA Securities Health Care Conference

UBS Maintains Neutral on Solventum, Lowers Price Target to $78

Solventum (SOLV) Q1 2026 Earnings Transcript

Stifel Maintains Buy on Solventum, Lowers Price Target to $90

Solventum (SOLV) Recently Broke Out Above the 20-Day Moving Average

Solventum (SOLV) Recently Broke Out Above the 50-Day Moving Average

Wells Fargo Maintains Equal-Weight on Solventum, Lowers Price Target to $70

Keybanc Maintains Overweight on Solventum, Raises Price Target to $93